Immunohistochemical and ultrastructural features of congenital melanocytic naevus cells support a stem-cell phenotype

British Journal of Dermatology

Volumn 169, Issue 2, 2013, Pages 374-383

  Kinsler, V A ^a,b   Anderson, G ^a   Latimer, B ^a   Natarajan, D ^b   Healy, E ^c   Moore, G E ^b   Sebire, N J ^a,b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CD133 ANTIGEN; CD14 ANTIGEN; CD163 ANTIGEN; CD20 ANTIGEN; CD34 ANTIGEN; CD68 ANTIGEN; FASCIN; KI 67 ANTIGEN; LYMPHOID ENHANCER FACTOR 1; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; NESTIN; PROTEIN S6;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CONGENITAL MELANOCYTIC NEVUS; CONTROLLED STUDY; EUKARYOTIC FLAGELLUM; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MELANOCYTE; MELANOCYTIC NEVUS; MICROVILLUS; MONOCYTE; NEVUS CELL; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STEM CELL; TRANSMISSION ELECTRON MICROSCOPY;

ANTIGENS, DIFFERENTIATION; ANTIGENS, NEOPLASM; CELL LINEAGE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASTIC STEM CELLS; NEVUS, PIGMENTED; PHENOTYPE; SKIN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84881565282     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12323     Document Type: Article

References (48)

1. Kinsler VA, Thomas AC, Ishida M, et al,. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol 2013 [Epub ahead of print].
2. Barnhill RL, Piepkorn MW, Busam KJ,. Pathology of Melanocytic Nevi and Malignant Melanoma. New York, NY: Springer, 2004.
3. Clemmensen OJ, Kroon S,. The histology of 'congenital features' in early acquired melanocytic nevi. J Am Acad Dermatol 1988; 19: 742-6.
4. Misago N,. The relationship between melanocytes and peripheral nerve sheath cells (Part I): melanocytic nevus (excluding so-called 'blue nevus') with peripheral nerve sheath differentiation. Am J Dermatopathol 2000; 22: 217-29.
5. McCann E, Fryer AE, Kokai G,. Congenital melanocytic naevus with associated neurofibroma and schwannoma-like change. Clin Dysmorphol 2005; 14: 159-60.
6. Leslie C,. Cartilaginous differentiation in a giant congenital melanocytic naevus. Pathology 2008; 40: 726-8.
7. Bastian BC, Xiong J, Frieden IJ, et al,. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas. Am J Pathol 2002; 161: 1163-9.
8. Krengel S,. Nevogenesis-new thoughts regarding a classical problem. Am J Dermatopathol 2005; 27: 456-65.
9. Cramer SF,. The histogenesis of acquired melanocytic nevi. Based on a new concept of melanocytic differentiation. Am J Dermatopathol 1984; 6 (Suppl.): 289-98.
10. Cramer SF,. The melanocytic differentiation pathway in congenital melanocytic nevi: theoretical considerations. Pediatr Pathol 1988; 8: 253-65.
11. Cramer SF, Fesyuk A,. On the development of neurocutaneous units-implications for the histogenesis of congenital, acquired, and dysplastic nevi. Am J Dermatopathol 2012; 34: 60-81.
12. Adameyko I, Lallemend F, Aquino JB, et al,. Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin. Cell 2009; 139: 366-79.
13. Dupin E, Real C, Glavieux-Pardanaud C, et al,. Reversal of developmental restrictions in neural crest lineages: transition from Schwann cells to glial-melanocytic precursors in vitro. Proc Natl Acad Sci USA 2003; 100: 5229-33.
14. Sherman L, Stocker KM, Morrison R, Ciment G,. Basic fibroblast growth factor (bFGF) acts intracellularly to cause the transdifferentiation of avian neural crest-derived Schwann cell precursors into melanocytes. Development 1993; 118: 1313-26.
15. Dupin E, Calloni G, Real C, et al,. Neural crest progenitors and stem cells. C R Biol 2007; 330: 521-9.
16. Barnhill RL, Chastain MA, Jerdan MS, et al,. Angiotropic neonatal congenital melanocytic nevus: how extravascular migration of melanocytes may explain the development of congenital nevi. Am J Dermatopathol 2010; 32: 495-9.
17. Kokta V, Hung T, Al Dhaybi R, et al,. High prevalence of angiotropism in congenital melanocytic nevi: an analysis of 53 cases. Am J Dermatopathol 2013; 35: 180-3.
18. Nishimura EK,. Melanocyte stem cells: a melanocyte reservoir in hair follicles for hair and skin pigmentation. Pigment Cell Melanoma Res 2011; 24: 401-10.
19. Nishikawa-Torikai S, Osawa M, Nishikawa SI,. Functional characterization of melanocyte stem cells in hair follicles. J Invest Dermatol 2011; 131: 2358-67.
20. Biernaskie J,. Human hair follicles: 'bulging' with neural crest-like stem cells. J Invest Dermatol 2010; 130: 1202-4.
21. Clewes O, Narytnyk A, Gillinder KR, et al,. Human epidermal neural crest stem cells (hEPI-NCSC)-characterization and directed differentiation into osteocytes and melanocytes. Stem Cell Rev 2011; 7: 799-814.
22. Osawa M, Egawa G, Mak SS, et al,. Molecular characterization of melanocyte stem cells in their niche. Development 2005; 132: 5589-99.
23. Yu H, Fang D, Kumar SM, et al,. Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am J Pathol 2006; 168: 1879-88.
24. Fernandes KJ, Toma JG, Miller FD,. Multipotent skin-derived precursors: adult neural crest-related precursors with therapeutic potential. Philos Trans R Soc Lond B Biol Sci 2008; 363: 185-98.
25. Toma JG, McKenzie IA, Bagli D, Miller FD,. Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 2005; 23: 727-37.
26. Toma JG, Akhavan M, Fernandes KJ, et al,. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 2001; 3: 778-84.
27. Fernandes KJ, McKenzie IA, Mill P, et al,. A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol 2004; 6: 1082-93.
28. Krengel S, Scope A, Dusza SW, et al,. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. J Am Acad Dermatol 2013; 68: 441-51.
29. Zabierowski SE, Herlyn M,. Melanoma stem cells: the dark seed of melanoma. J Clin Oncol 2008; 26: 2890-4.
30. Al Dhaybi R, Sartelet H, Powell J, Kokta V,. Expression of CD133+ cancer stem cells in childhood malignant melanoma and its correlation with metastasis. Mod Pathol 2010; 23: 376-80.
31. Grichnik JM, Burch JA, Schulteis RD, et al,. Melanoma, a tumor based on a mutant stem cell? J Invest Dermatol 2006; 126: 142-53.
32. Hoerter JD, Bradley P, Casillas A, et al,. Extrafollicular dermal melanocyte stem cells and melanoma. Stem Cells Int 2012; 2012: 407079.
33. Klein WM, Wu BP, Zhao S, et al,. Increased expression of stem cell markers in malignant melanoma. Mod Pathol 2007; 20: 102-7.
34. Schatton T, Murphy GF, Frank NY, et al,. Identification of cells initiating human melanomas. Nature 2008; 451: 345-9.
35. Zabierowski SE, Fukunaga-Kalabis M, Li L, Herlyn M,. Dermis-derived stem cells: a source of epidermal melanocytes and melanoma? Pigment Cell Melanoma Res 2011; 24: 422-9.
36. Piras F, Perra MT, Murtas D, et al,. The stem cell marker nestin predicts poor prognosis in human melanoma. Oncol Rep 2010; 23: 17-24.
37. Ehrmann J, Kolar Z, Mokry J,. Nestin as a diagnostic and prognostic marker: immunohistochemical analysis of its expression in different tumours. J Clin Pathol 2005; 58: 222-3.
38. Goncharuk VN, Ross JS, Carlson JA,. Actin-binding protein fascin expression in skin neoplasia. J Cutan Pathol 2002; 29: 430-8.
39. Yildiz L, Kefeli M, Aydin O, Kandemir B,. Fascin expression in melanocytic lesions of the skin. Eur J Dermatol 2009; 19: 445-50.
40. Salgado CM, Davis A, Heider A, et al,. Cellular dynamics in congenital melanocytic nevi: is 'maturation with depth' a one-way road? Presented at the XXI International Pigment Cell Conference, Bordeaux, France, 21-24 September 2011.
41. Wollina U, Kilian U, Henkel U, et al,. The initial steps of tumor progression in melanocytic lineage: a histochemical approach. Anticancer Res 1991; 11: 1405-14.
42. Karbowniczek M, Spittle CS, Morrison T, et al,. mTOR is activated in the majority of malignant melanomas. J Invest Dermatol 2008; 128: 980-7.
43. Jensen TO, Schmidt H, Steiniche T, et al,. Melanoma cell expression of macrophage markers in AJCC stage I/II melanoma. J Clin Oncol 2010; 28 (Suppl.): e19034.
44. Maie O, Schneider BV,. The ultrastructure of congenital nevocytic nevi. II. Nevus cell morphology and contacts with nerve fibers. Arch Dermatol Res 1986; 278: 398-406.
45. Schneider BV, Maie O,. The ultrastructure of congenital nevocytic nevi. I. Nevus cells in walls of blood vessels and lymphatics. Arch Dermatol Res 1985; 278: 49-56.
46. Schneider BV, Schnyder UW,. The ultrastructure of congenital naevocytic naevi. III. Morphological variability of melanosomes. Arch Dermatol Res 1991; 283: 438-44.
47. Dadzie OE, Goerig R, Bhawan J,. Incidental microscopic foci of nevic aggregates in skin. Am J Dermatopathol 2008; 30: 45-50.
48. Kinsler VA, Birley J, Atherton DJ,. Great Ormond Street Hospital for Children Registry for Congenital Melanocytic Naevi: prospective study 1988-2007. Part 2-evaluation of treatments. Br J Dermatol 2009; 160: 387-92.